NL1005037C2 - Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten. - Google Patents
Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten. Download PDFInfo
- Publication number
- NL1005037C2 NL1005037C2 NL1005037A NL1005037A NL1005037C2 NL 1005037 C2 NL1005037 C2 NL 1005037C2 NL 1005037 A NL1005037 A NL 1005037A NL 1005037 A NL1005037 A NL 1005037A NL 1005037 C2 NL1005037 C2 NL 1005037C2
- Authority
- NL
- Netherlands
- Prior art keywords
- casein
- caseinate
- protein
- preparation
- milk
- Prior art date
Links
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title claims description 190
- 102000011632 Caseins Human genes 0.000 title claims description 186
- 108010076119 Caseins Proteins 0.000 title claims description 186
- 235000021240 caseins Nutrition 0.000 title claims description 182
- 239000005018 casein Substances 0.000 title claims description 175
- 229940071162 caseinate Drugs 0.000 title claims description 74
- 108010011756 Milk Proteins Proteins 0.000 title claims description 61
- 102000014171 Milk Proteins Human genes 0.000 title claims description 59
- 235000021239 milk protein Nutrition 0.000 title claims description 59
- 238000000034 method Methods 0.000 title claims description 52
- 108010046377 Whey Proteins Proteins 0.000 title claims description 29
- 235000021119 whey protein Nutrition 0.000 title claims description 22
- 230000003301 hydrolyzing effect Effects 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 claims description 86
- 108091005804 Peptidases Proteins 0.000 claims description 64
- 102000035195 Peptidases Human genes 0.000 claims description 64
- 230000007062 hydrolysis Effects 0.000 claims description 59
- 238000006460 hydrolysis reaction Methods 0.000 claims description 59
- 235000018102 proteins Nutrition 0.000 claims description 58
- 102000004169 proteins and genes Human genes 0.000 claims description 58
- 108090000623 proteins and genes Proteins 0.000 claims description 57
- 235000004252 protein component Nutrition 0.000 claims description 54
- 235000019833 protease Nutrition 0.000 claims description 50
- 230000000890 antigenic effect Effects 0.000 claims description 41
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 33
- 229940098773 bovine serum albumin Drugs 0.000 claims description 33
- 239000012634 fragment Substances 0.000 claims description 33
- 108700031875 bovine (152-168) serum albumin Proteins 0.000 claims description 28
- 238000000108 ultra-filtration Methods 0.000 claims description 27
- 239000012528 membrane Substances 0.000 claims description 21
- 239000008267 milk Substances 0.000 claims description 19
- 210000004080 milk Anatomy 0.000 claims description 19
- 235000013336 milk Nutrition 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 14
- 102000007544 Whey Proteins Human genes 0.000 claims description 13
- 238000000926 separation method Methods 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 10
- 230000001900 immune effect Effects 0.000 claims description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000003531 protein hydrolysate Substances 0.000 claims description 9
- 239000005862 Whey Substances 0.000 claims description 7
- 230000008105 immune reaction Effects 0.000 claims description 7
- 102000008192 Lactoglobulins Human genes 0.000 claims description 6
- 108010060630 Lactoglobulins Proteins 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 235000020247 cow milk Nutrition 0.000 claims description 6
- 235000013350 formula milk Nutrition 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims description 5
- 235000014655 lactic acid Nutrition 0.000 claims description 5
- 239000004310 lactic acid Substances 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 4
- 238000010324 immunological assay Methods 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 102000004407 Lactalbumin Human genes 0.000 claims description 3
- 108090000942 Lactalbumin Proteins 0.000 claims description 3
- 208000009793 Milk Hypersensitivity Diseases 0.000 claims description 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 3
- 235000021241 α-lactalbumin Nutrition 0.000 claims description 3
- 108060003951 Immunoglobulin Proteins 0.000 claims description 2
- 102000018358 immunoglobulin Human genes 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 101710089384 Extracellular protease Proteins 0.000 claims 1
- 241000194035 Lactococcus lactis Species 0.000 claims 1
- 201000010859 Milk allergy Diseases 0.000 claims 1
- 235000014897 Streptococcus lactis Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 17
- 229940027941 immunoglobulin g Drugs 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 238000002965 ELISA Methods 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 239000012465 retentate Substances 0.000 description 9
- 229940021722 caseins Drugs 0.000 description 8
- 239000012466 permeate Substances 0.000 description 8
- 230000002163 immunogen Effects 0.000 description 7
- 238000004007 reversed phase HPLC Methods 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000013351 cheese Nutrition 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000021247 β-casein Nutrition 0.000 description 4
- JDIIGWSSTNUWGK-UHFFFAOYSA-N 1h-imidazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C=CN=C1 JDIIGWSSTNUWGK-UHFFFAOYSA-N 0.000 description 3
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 3
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 2
- 108090000746 Chymosin Proteins 0.000 description 2
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229940080701 chymosin Drugs 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000000774 hypoallergenic effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 2
- 235000019624 protein content Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 241000194105 Paenibacillus polymyxa Species 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004682 mucosal barrier function Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000008684 selective degradation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- -1 α-Lac Proteins 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1005037A NL1005037C2 (nl) | 1997-01-17 | 1997-01-17 | Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten. |
| US09/341,785 US6451552B1 (en) | 1997-01-17 | 1998-01-16 | Method for the selective degradation of milk protein in the presence of other milk proteins |
| NZ336810A NZ336810A (en) | 1997-01-17 | 1998-01-16 | Method for the selective degradation of casein or caseinate in the presence of other milk proteins |
| EEP199900297A EE9900297A (et) | 1997-01-17 | 1998-01-16 | Piimavalkude selektiivse lagundamise meetod teiste piimavalkude manulusel |
| CA002277899A CA2277899A1 (fr) | 1997-01-17 | 1998-01-16 | Procede de degradation selective de proteines du lait en presence d'autres proteines du lait |
| BR9806911-0A BR9806911A (pt) | 1997-01-17 | 1998-01-16 | Processos para hidrólise seletiva de caseina/caseinato, para preparar uma preparação de proteìna de leite hidrolisada, para preparar um hidrolisado de proteìna de leite, e para preparar uma preparação de proteìna que possui um nìvel de caseìna reduzido, uso de uma proteinase especìfica para caseìna/caseinato, hidrolisado de proteìna de leite, uso do mesmo, preparação de proteìna de leite esgotada de caseìna, e, uso da mesma. |
| EP98900763A EP0959690A1 (fr) | 1997-01-17 | 1998-01-16 | Procede de degradation selective de proteines du lait en presence d'autres proteines du lait |
| AU55780/98A AU734222B2 (en) | 1997-01-17 | 1998-01-16 | Method for the selective degradation of milk protein in the presence of other m ilk proteins |
| PCT/NL1998/000025 WO1998031239A1 (fr) | 1997-01-17 | 1998-01-16 | Procede de degradation selective de proteines du lait en presence d'autres proteines du lait |
| JP53416898A JP2001516204A (ja) | 1997-01-17 | 1998-01-16 | 他の乳タンパクの存在下での乳タンパクの選択的分解方法 |
| KR1019997006458A KR20000070231A (ko) | 1997-01-17 | 1998-01-16 | 다른 우유 단백질 존재 하에 우유 단백질을 선택적으로 분해하는 방법 |
| IL13096998A IL130969A (en) | 1997-01-17 | 1998-01-16 | A method for selective degradation of milk protein in the presence of other milk proteins |
| NO993424A NO993424L (no) | 1997-01-17 | 1999-07-12 | FremgangsmÕte til selektiv nedbrytning av melkeprotein i nærvær av andre melkeproteiner |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1005037A NL1005037C2 (nl) | 1997-01-17 | 1997-01-17 | Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten. |
| NL1005037 | 1997-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL1005037C2 true NL1005037C2 (nl) | 1998-07-20 |
Family
ID=19764239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL1005037A NL1005037C2 (nl) | 1997-01-17 | 1997-01-17 | Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6451552B1 (fr) |
| EP (1) | EP0959690A1 (fr) |
| JP (1) | JP2001516204A (fr) |
| KR (1) | KR20000070231A (fr) |
| AU (1) | AU734222B2 (fr) |
| BR (1) | BR9806911A (fr) |
| CA (1) | CA2277899A1 (fr) |
| EE (1) | EE9900297A (fr) |
| IL (1) | IL130969A (fr) |
| NL (1) | NL1005037C2 (fr) |
| NO (1) | NO993424L (fr) |
| NZ (1) | NZ336810A (fr) |
| WO (1) | WO1998031239A1 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9927603D0 (en) * | 1999-11-22 | 2000-01-19 | Nestle Sa | Use of a milk protein hydrolysate in the treatment of diabetes |
| AU2167901A (en) * | 1999-12-17 | 2001-06-25 | N.V. Nutricia | Use of modified foodstuff ingredients for preventing the development of a diabetes mellitus (iddm) with an existing epidemiologically established risk |
| US20030224096A1 (en) * | 2002-06-04 | 2003-12-04 | Novozymes A/S | Whey protein hydrolysate |
| US7393659B2 (en) * | 2002-08-29 | 2008-07-01 | Abbott Laboratories | Analytical method for the determination of infant formula protein digestibility in vitro |
| WO2005021589A1 (fr) | 2003-08-30 | 2005-03-10 | Nestec S.A. | Proteines solubles dans l'acide issues de caseine micellaire |
| WO2005072056A2 (fr) | 2004-01-28 | 2005-08-11 | Develogen Israel Ltd. | Therapie hsp associee a un regime a faible antigenicite |
| WO2007113279A1 (fr) * | 2006-03-31 | 2007-10-11 | Dsm Ip Assets B.V. | Procédé d'hydrolyse de protéines de lait |
| JP2008189637A (ja) * | 2007-02-08 | 2008-08-21 | Snow Brand Milk Prod Co Ltd | 自己免疫疾患予防剤 |
| BRPI0913178B1 (pt) | 2008-06-03 | 2020-05-19 | Novozymes As | método para produzir um hidrolisado de caseína, e, uso de um hidrolisado de caseína |
| EP2258208A1 (fr) * | 2009-06-02 | 2010-12-08 | University of Limerick | Produit de protéine avec une immunogénicité modifiée |
| EP2489281A1 (fr) * | 2011-02-17 | 2012-08-22 | University of Limerick | Hydrolysat de caséine |
| EP2583564A1 (fr) * | 2011-10-21 | 2013-04-24 | Nestec S.A. | Utilisation de micelles de protéine de lactosérum pour améliorer le profil d'insuline chez les patients diabétiques |
| US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
| US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
| US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
| US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| EP2845863A1 (fr) * | 2013-09-10 | 2015-03-11 | Consejo Superior de Investigaciones Cientificas (CSIC) | Mathanococcus jannaschii protease et son utilisation |
| WO2019141662A1 (fr) | 2018-01-16 | 2019-07-25 | Frieslandcampina Nederland B.V. | Préparation pour nourrissons hypoallergénique et procédés pour la préparation de celle-ci |
| CN114504051B (zh) * | 2022-03-10 | 2023-05-02 | 中国海洋大学 | 一种基于分子模拟的凝乳酶预处理高效降解酪蛋白抗原性的方法 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0226221A1 (fr) * | 1985-12-18 | 1987-06-24 | Ernst-Gunnar Samuelsson | Préparation peptidique, son procédé de préparation et utilisation de la préparation peptidique |
| EP0421309A2 (fr) * | 1989-10-02 | 1991-04-10 | SANDOZ NUTRITION Ltd. | Hydrolysates de protéines |
| WO1993008702A1 (fr) * | 1991-11-08 | 1993-05-13 | Novo Nordisk A/S | Hydrolysat de caseine et son procede de production |
| EP0601802A1 (fr) * | 1992-12-10 | 1994-06-15 | Valio Ltd. | Un procédé pour élimener des composés allergéniques d'un mélange de protéines, produit obtenu et son utilisation |
| JPH06261691A (ja) * | 1993-03-16 | 1994-09-20 | Snow Brand Milk Prod Co Ltd | 低アレルゲン性乳蛋白質の製造法 |
| EP0631731A1 (fr) * | 1993-06-30 | 1995-01-04 | Bristol-Myers Squibb Company | Hydrolysat partiel de protéines de lait, et procédé de préparation |
| JPH07203844A (ja) * | 1994-01-12 | 1995-08-08 | Morinaga Milk Ind Co Ltd | 乳化性及び熱安定性に優れた乳清蛋白質分解物の製造 法、並びに該乳清蛋白質分解物を使用した抗アレルギ ー性調製乳 |
| JPH08238059A (ja) * | 1995-03-03 | 1996-09-17 | Amano Pharmaceut Co Ltd | 低アレルゲン性乳蛋白質の製造法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK595285D0 (da) | 1985-12-20 | 1985-12-20 | Nordisk Gentofte | Injicerbart og varmebehandet igg-praeparat og fremgangsmaade til fremstilling af samme |
| CA1333471C (fr) * | 1988-04-29 | 1994-12-13 | Gustavo Bounous | Lactalbumine utilisee comme supplement alimentaire |
| NL8901994A (nl) * | 1989-08-02 | 1991-03-01 | Dmv Campina Bv | Aminopeptidase. |
| EP0522203A1 (fr) * | 1991-05-16 | 1993-01-13 | Probicom Research B.V. | Protéine de bactéries produisant l'acide lactique |
| WO1994006917A1 (fr) * | 1992-09-18 | 1994-03-31 | Unilever N.V. | Production de proteines ou de polypeptides souhaites par mise en culture d'une bacterie d'acide lactique transformee |
| ES2213164T3 (es) * | 1994-10-26 | 2004-08-16 | Novozymes A/S | Metodo de produccion de un hidrolizado de proteina de leche. |
-
1997
- 1997-01-17 NL NL1005037A patent/NL1005037C2/nl not_active IP Right Cessation
-
1998
- 1998-01-16 EE EEP199900297A patent/EE9900297A/xx unknown
- 1998-01-16 WO PCT/NL1998/000025 patent/WO1998031239A1/fr not_active Ceased
- 1998-01-16 EP EP98900763A patent/EP0959690A1/fr not_active Withdrawn
- 1998-01-16 KR KR1019997006458A patent/KR20000070231A/ko not_active Withdrawn
- 1998-01-16 AU AU55780/98A patent/AU734222B2/en not_active Ceased
- 1998-01-16 JP JP53416898A patent/JP2001516204A/ja active Pending
- 1998-01-16 NZ NZ336810A patent/NZ336810A/en unknown
- 1998-01-16 CA CA002277899A patent/CA2277899A1/fr not_active Abandoned
- 1998-01-16 US US09/341,785 patent/US6451552B1/en not_active Expired - Fee Related
- 1998-01-16 IL IL13096998A patent/IL130969A/en not_active IP Right Cessation
- 1998-01-16 BR BR9806911-0A patent/BR9806911A/pt not_active Application Discontinuation
-
1999
- 1999-07-12 NO NO993424A patent/NO993424L/no unknown
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0226221A1 (fr) * | 1985-12-18 | 1987-06-24 | Ernst-Gunnar Samuelsson | Préparation peptidique, son procédé de préparation et utilisation de la préparation peptidique |
| EP0421309A2 (fr) * | 1989-10-02 | 1991-04-10 | SANDOZ NUTRITION Ltd. | Hydrolysates de protéines |
| WO1993008702A1 (fr) * | 1991-11-08 | 1993-05-13 | Novo Nordisk A/S | Hydrolysat de caseine et son procede de production |
| EP0601802A1 (fr) * | 1992-12-10 | 1994-06-15 | Valio Ltd. | Un procédé pour élimener des composés allergéniques d'un mélange de protéines, produit obtenu et son utilisation |
| JPH06261691A (ja) * | 1993-03-16 | 1994-09-20 | Snow Brand Milk Prod Co Ltd | 低アレルゲン性乳蛋白質の製造法 |
| EP0631731A1 (fr) * | 1993-06-30 | 1995-01-04 | Bristol-Myers Squibb Company | Hydrolysat partiel de protéines de lait, et procédé de préparation |
| JPH07203844A (ja) * | 1994-01-12 | 1995-08-08 | Morinaga Milk Ind Co Ltd | 乳化性及び熱安定性に優れた乳清蛋白質分解物の製造 法、並びに該乳清蛋白質分解物を使用した抗アレルギ ー性調製乳 |
| JPH08238059A (ja) * | 1995-03-03 | 1996-09-17 | Amano Pharmaceut Co Ltd | 低アレルゲン性乳蛋白質の製造法 |
Non-Patent Citations (4)
| Title |
|---|
| B. KIEFER-PARTSCH ET AL: "Purification of an X-prolyl-dipeptidyl aminopeptidase from the cell wall proteolytic system of Lactococcus lactis subsp. cremoris", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 31, no. 1, 1989, pages 75-78, XP002039530 * |
| DATABASE WPI Section Ch Week 9442, Derwent World Patents Index; Class D13, AN 94-337356, XP002039532 * |
| DATABASE WPI Section Ch Week 9540, Derwent World Patents Index; Class B04, AN 95-307065, XP002039533 * |
| DATABASE WPI Section Ch Week 9647, Derwent World Patents Index; Class D13, AN 96-471202, XP002039531 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EE9900297A (et) | 2000-02-15 |
| AU5578098A (en) | 1998-08-07 |
| US6451552B1 (en) | 2002-09-17 |
| KR20000070231A (ko) | 2000-11-25 |
| AU734222B2 (en) | 2001-06-07 |
| JP2001516204A (ja) | 2001-09-25 |
| BR9806911A (pt) | 2000-05-16 |
| EP0959690A1 (fr) | 1999-12-01 |
| IL130969A (en) | 2002-11-10 |
| NO993424L (no) | 1999-09-15 |
| NZ336810A (en) | 2001-08-31 |
| IL130969A0 (en) | 2001-01-28 |
| US20020061548A1 (en) | 2002-05-23 |
| WO1998031239A1 (fr) | 1998-07-23 |
| NO993424D0 (no) | 1999-07-12 |
| CA2277899A1 (fr) | 1998-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL1005037C2 (nl) | Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten. | |
| Abd El-Salam et al. | Preparation, properties, and uses of enzymatic milk protein hydrolysates | |
| RU2292155C2 (ru) | Способ гидролиза молочных белков | |
| CA1336307C (fr) | Procede de preparation d'un peptide hydrosoluble thermoresistant non amer, produit obtenu par ce procede et produits nutritifs, breuvages et produits dietetiques en renfermant | |
| AU2007343749B2 (en) | Milk protein hydrolyzates with reduced immunogenic potential | |
| JP5643099B2 (ja) | 改質乳の製造方法 | |
| EP0353122A1 (fr) | Hydrolysat partiel de protéines de lactosérum, procédé enzymatique de préparation de cet hydrolysat, et aliment lacté diététique hypoallergénique le contenant | |
| JP2001506858A (ja) | タンパク質加水分解物の製造方法 | |
| WO1992013964A1 (fr) | Preparations proteiques | |
| Wohlrab et al. | Purification and characterization of a dipeptidase from Lactobacillus delbrueckii subsp. bulgaricus | |
| López-Fandiño et al. | Comparative study by HPLC of caseinomacropeptides from cows', ewes' and goats' milk | |
| JP2003250460A (ja) | 乳蛋白質の機能性改質方法 | |
| LIN et al. | Debittering casein hydrolysates with octadecyl‐siloxane (C18) columns | |
| RU2428047C1 (ru) | Способ получения гидролизата сывороточных белков с высокой степенью гидролиза и гидролизат сывороточных белков с высокой степенью гидролиза | |
| Exterkate et al. | Characterization of the cell wall proteinase PIII of Lactococcus lactis subsp. cremoris strain AM1, and its relationship with the catalytically different cell wall proteinase PI/PII of strain HP | |
| JP3071877B2 (ja) | 経口寛容誘導能を有する低アレルゲン性酵素分解ペプチド組成物 | |
| NZ528190A (en) | Cheese making process | |
| JPH06343422A (ja) | オリゴペプチド混合物及びその製造法 | |
| Alting et al. | Selective hydrolysis of milk proteins to facilitate the elimination of the ABBOS epitope of bovine serum albumin and other immunoreactive epitopes | |
| Donnelly | Applications of biotechnology and separation technology in dairy processing | |
| JPH05344847A (ja) | 不快味のない低抗原性たん白質分解物 及びその製造方法 | |
| RU2531164C1 (ru) | Способ получения низкогидролизованной пептидной композиции из белков молочной сыворотки | |
| JPH05137515A (ja) | 不快味のない低抗原性たん白質分解物 及びその製造方法 | |
| JPH08126488A (ja) | 新規ジペプチダーゼ | |
| JPH08245690A (ja) | 二糖類分解酵素活性促進ペプチド |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD2B | A search report has been drawn up | ||
| VD1 | Lapsed due to non-payment of the annual fee |
Effective date: 20040801 |